JW Therapeutics Announces Strategic Partnership with MediTrust Health

23 August 2021 | Monday | News


JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy, today announced that it has entered into a strategic partnership with MediTrust Health.
Image Source : Public Domain

Image Source : Public Domain

Leveraging the respective business advantages, both parties plan to strengthen cooperation in supplementary medical insurance and health insurance policy, to relieve the payment burden of patients and improve the accessibility of CAR-T therapy through private commercial insurance policy.

Meanwhile, both parties jointly held a seminar on "Establishing the Multi-tiered Medical Insurance System for CAR-T Therapy" and conducted in-depth discussions on topics such as how to establish the multi-tiered private healthcare insurance system and innovative payment system.

News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close